logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Invasive Pulmonary Aspergillosis

    FiltersReset Filters
    10 results

    • caspofungin acetate

      (Caspofungin Acetate)
      Fosun Pharma USA Inc.
      Usage: Caspofungin acetate is indicated for empirical treatment of presumed fungal infections in febrile, neutropenic patients, and for treating candidemia, various Candida infections, esophageal candidiasis, and invasive aspergillosis in patients intolerant to other therapies, with specific limitations for certain conditions.

    • caspofungin acetate

      (CASPOFUNGIN ACETATE)
      Areva Pharmaceuticals
      Usage: Caspofungin acetate is indicated for empirical therapy of presumed fungal infections in febrile, neutropenic patients, treatment of candidemia and other Candida infections, esophageal candidiasis, and invasive aspergillosis in patients intolerant to other therapies. It is not approved for certain conditions like oropharyngeal candidiasis or initial invasive aspergillosis therapy.

    • caspofungin acetate

      (Caspofungin Acetate)
      Gland Pharma Limited
      Usage: Caspofungin acetate is indicated for the empirical treatment of presumed fungal infections in febrile, neutropenic patients, treatment of candidemia, esophageal candidiasis, and invasive aspergillosis in patients intolerant to other therapies, in adults and pediatric patients aged 3 months and older. Limitations apply for specific infections.

    • posaconazole

      (posaconazole)
      Par Pharmaceutical Inc.
      Usage: Posaconazole delayed-release tablets are indicated for treating invasive aspergillosis in patients aged 13 and older. It also prophylaxes invasive Aspergillus and Candida infections in severely immunocompromised patients. The oral suspension is approved for treating oropharyngeal candidiasis, including cases resistant to itraconazole or fluconazole in patients 13 and older.

    • posaconazole

      (posaconazole)
      Mylan Institutional LLC
      Usage: Posaconazole injection is indicated for treating invasive aspergillosis in patients aged 13 and older and for prophylaxis against invasive Aspergillus and Candida infections in severely immunocompromised patients, including those with graft-versus-host disease or prolonged neutropenia from chemotherapy, starting at age 2.

    • vfend

      (Voriconazole)
      Roerig
      Usage: VFEND is indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium and Fusarium species in adults and pediatric patients (2 years and older) intolerant to or refractory to other therapies.

    • voriconazole

      (voriconazole)
      Sandoz Inc
      Usage: Voriconazole tablets are indicated for the treatment of invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium and Fusarium species in patients aged 2 years and older, particularly those intolerant or refractory to other therapies.

    • voriconazole

      (Voriconazole)
      Greenstone LLC
      Usage: Voriconazole is indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp. in patients 2 years and older who are intolerant or refractory to other therapies.

    • voriconazole

      (voriconazole)
      Slate Run Pharmaceuticals
      Usage: Voriconazole for injection is indicated for adults and pediatric patients (2 years and older) to treat invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium species, especially when other therapies are ineffective or intolerable.

    • voriconazole

      (Voriconazole)
      Eugia US LLC
      Usage: Voriconazole for injection is indicated for treating invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, and serious fungal infections caused by Scedosporium and Fusarium species in patients intolerant to or refractory to other therapies. Suitable for adults and pediatric patients aged 2 years and older.